2020
DOI: 10.1213/ane.0000000000004982
|View full text |Cite
|
Sign up to set email alerts
|

Can Pediatric COVID-19 Testing Sensitivity Be Improved With Sequential Tests?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…Reverse transcriptase‐polymerase chain reaction (RT‐PCR) assays remain the molecular test of choice for diagnosis of coronavirus disease 2019 (COVID‐19) (1). Many factors, however, influence the quality of the test (and thus the sensitivity), including swab technique, the child's viral load, and predominant viral replication site (nasopharyngeal vs lower airway) (2). Although RT‐PCR itself is generally sensitive and specific for SARS‐CoV‐2 (1), the sensitivity and specificity of the “testing system” needs to be considered as a whole, including the ability to collect the proper respiratory tract specimen at the right time from the right anatomic site in a child.…”
mentioning
confidence: 99%
“…Reverse transcriptase‐polymerase chain reaction (RT‐PCR) assays remain the molecular test of choice for diagnosis of coronavirus disease 2019 (COVID‐19) (1). Many factors, however, influence the quality of the test (and thus the sensitivity), including swab technique, the child's viral load, and predominant viral replication site (nasopharyngeal vs lower airway) (2). Although RT‐PCR itself is generally sensitive and specific for SARS‐CoV‐2 (1), the sensitivity and specificity of the “testing system” needs to be considered as a whole, including the ability to collect the proper respiratory tract specimen at the right time from the right anatomic site in a child.…”
mentioning
confidence: 99%
“…There have been no identified cases of perioperative spread from our hospital-implemented practices. There are multiple limitations in PCR testing that should be appropriately recognized (16,17). Although no COVID-19 panacea test exists, we are mitigating risk by considering our incidence/prevalence, screening for symptoms, and testing before endoscopic procedures to prioritize respirators to the highest risk scenarios.…”
mentioning
confidence: 99%